N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.

Схожие документы

• N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.
  по: Fischer, P B, et al.
  Опубликовано: (1996)
• The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
  по: Fischer, P B, et al.
  Опубликовано: (1995)
• Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41
  по: Lu, Lu, et al.
  Опубликовано: (2016)
• Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
  по: Pu, Jing, et al.
  Опубликовано: (2019)
• Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
  по: Back, N K, et al.
  Опубликовано: (1993)